METHOD FOR TREATING MYASTHENIA GRAVIS WITH TACI-FC FUSION PROTEIN

Abstract: provided are a drug, a dosage regimen, an administration interval and an administration mode for treating myasthenia gravis by means of using taci-fc fusion protein. results show that the provided taci-fc fusion protein exhibits a good clinical efficacy and safety in the treatment of patients with myasthenia gravis.

Inventor(s): Jianmin FANG, Wenxiang WANG

CPC Classification: A61K38/177 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250186548